The FDA may give drug manufacturer Purdue Pharma a six-month extension of its original OxyContin patent as an incentive for the completed pediatric study.
Related Articles on Pain Management:
Study: Hospitals Struggle With Pediatric Pain
Pain Management Physician Joins Coastal Orthopedics
Report: Florida Closed Half of Pain Management Clinics in Two Years
